Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
Canada
Politics
World
En français
Sports
Business
Lifestyle
AI
Tech
Science

European Medicines Agency
EU
EU/Ukraine
European Commission
Ursula von der Leyen
EU/Russia
GDPR
European Parliament
ETIAS
EU/China
EU Summit
European Central Bank
Topics

Advertisement

Advertisement

European Medicines Agency

Share

Top Latest Popular

Biocon's Pertuzumab gets EMA CHMP recommendation for breast cancer care The Business Standard 2d

The Business Standard 2d

Biocon gains as Pertuzumab biosimilar gets positive EMA recommendation The Business Standard 2d

The Business Standard 2d

Biocon Biologics receives positive CHMP opinion for Pertuzumab biosimilar The Business Standard 2d

The Business Standard 2d

Advertisement

Advertisement

Biocon arm gets positive EMA panel recommendation for breast cancerbiosimilar Pebrilzo The Economic Times 2d

The Economic Times 2d

European Commission

Biocon spurts 3% as Pertuzumab drug moves closer to marketing nod in Europe The Business Standard 2d

The Business Standard 2d

EMA backs 12 new medicines, alongside key label expansions EU Reporter 4d

EU Reporter 4d

Advertisement

Advertisement

Latest

Yesterday

Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market PR Newswire (Press Release) 15:00 Tue, 22 Sep

Biocon's Pertuzumab Becomes First Biosimilar to Secure EMA Chmp Approval Recommendation Under New Tailored Clinical Approach PR Newswire (Press Release) 12:59 Tue, 22 Sep

Monday

FDA reviewing contraceptives tied to meningioma risk Taipei Times 10:13 Mon, 21 Sep

Biocon arm gets positive EMA panel recommendation for breast cancerbiosimilar Pebrilzo The Economic Times 09:10 Mon, 21 Sep

Biocon spurts 3% as Pertuzumab drug moves closer to marketing nod in Europe The Business Standard 06:51 Mon, 21 Sep

Biocon gains as Pertuzumab biosimilar gets positive EMA recommendation The Business Standard 06:41 Mon, 21 Sep

Taiwan drug regulator reassessing safety of contraceptives linked to tumors Focus Taiwan 06:28 Mon, 21 Sep

Biocon's Pertuzumab gets EMA Chmp recommendation for breast cancer care The Business Standard 06:07 Mon, 21 Sep

Biocon Biologics receives positive Chmp opinion for Pertuzumab biosimilar The Business Standard 05:09 Mon, 21 Sep

Saturday

EMA backs 12 new medicines, alongside key label expansions EU Reporter 10:09 Sat, 19 Sep

Advertisement

Advertisement

Advertisement

Advertisement

About our EMA news

Latest news on the European Medicines Agency, also known as the EMA, a European Union agency responsible for the evaluation and supervision of pharmaceuticals.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Europe Europe
- Back to Europe European Union
  - Ursula von der Leyen
  - Josep Borrell
  - Digital Services Act
  - ECB ECB
  - Erasmus Erasmus
  - EU Summit EU Summit
  - Europol Europol
  - Eurozone Eurozone
  - MEPs MEPs
  - European Commission
  - European Court of Justice
  - European Environment Agency
  - European Investment Bank
  - European Medicines Agency
  - European Parliament
  - Frontex Frontex
  - ETIAS ETIAS
  - GDPR GDPR
  - Global Gateway
  - Schengen Schengen
  - EU/Belarus EU/Belarus
  - EU/China EU/China
  - EU/Hungary EU/Hungary
  - EU/India EU/India
  - EU/Qatar EU/Qatar
  - EU/Russia EU/Russia
  - EU/Ukraine EU/Ukraine